# C_2007266EN.01000701.xml

| 8.11.2007 | EN | Official Journal of the European Union | C 266/7 |
| --- | --- | --- | --- |

8.11.2007

EN

Official Journal of the European Union

C 266/7

---

Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the first half of 2006

(2007/C 266/05)

Subcommittee I — On the free movement of goods

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note, at the meeting on 8 December 2006, the following lists concerning marketing authorisations for medicinal products for the period 1 January-30 June 2006:

| ANNEX I | List of new marketing authorisations |
| --- | --- |
| ANNEX II | List of renewed marketing authorisations |
| ANNEX III | List of extended marketing authorisations |
| ANNEX IV | List of withdrawn marketing authorisations |
| ANNEX V | List of suspended marketing authorisations |

ANNEX I

List of new marketing authorisations

ANNEX II

List of renewed marketing authorisations

ANNEX III

List of extended marketing authorisations

ANNEX IV

List of withdrawn marketing authorisations

ANNEX V

List of suspended marketing authorisations

---

ANNEX I

List of new marketing authorisations

The following marketing authorisations have been granted in the EEA EFTA States during the period 1 January-30 June 2006:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/01/183/020-029 | HBVAXPRO | Liechtenstein | 28.2.2006 |
| EU/1/01/187/001 | DepoCyte | Liechtenstein | 31.1.2006 |
| EU/1/03/258/015-022 | Avandamet | Liechtenstein | 28.2.2006 |
| EU/1/03/262/001-006 | Emend | Liechtenstein | 31.1.2006 |
| EU/1/03/265/003-004 | Bonviva | Liechtenstein | 31.1.2006 |
| EU/1/03/266/001-002 | Bondenza | Liechtenstein | 28.2.2006 |
| EU/1/04/307/005-010 | Zonegran | Liechtenstein | 31.1.2006 |
| EU/1/05/322/001 | Yttriga | Liechtenstein | 31.1.2006 |
| EU/1/05/322/001/IS | Yttriga | Iceland | 17.2.2006 |
| EU/1/05/322/001/NO | Yttriga | Norway | 10.2.2006 |
| EU/1/05/323/001/NO-011/NO | ProQuad | Norway | 24.4.2006 |
| EU/1/05/323/001-011 | ProQuad | Liechtenstein | 30.4.2006 |
| EU/1/05/323/001-011/IS | ProQuad | Iceland | 25.4.2006 |
| EU/1/05/324/001 | Naglazyme | Liechtenstein | 31.1.2006 |
| EU/1/05/324/001/IS | Naglazyme | Iceland | 22.6.2006 |
| EU/1/05/324/01/NO | Naglazyme | Norway | 23.2.2006 |
| EU/1/05/325/001 | Macugen | Liechtenstein | 28.2.2006 |
| EU/1/05/325/001/IS | Macugen | Iceland | 10.3.2006 |
| EU/1/05/325/001/NO | Macugen | Norway | 2.3.2006 |
| EU/1/05/326/001 | Ionsys | Liechtenstein | 31.1.2006 |
| EU/1/05/326/001/IS | Ionsys | Iceland | 22.2.2006 |
| EU/1/05/326/001/NO | Ionsys | Norway | 16.2.2006 |
| EU/1/05/327/001/NO-017/NO | Exubera | Norway | 16.2.2006 |
| EU/1/05/327/001-017 | Exubera | Liechtenstein | 31.1.2006 |
| EU/1/05/327/001-017/IS | Exubera | Iceland | 22.3.2006 |
| EU/1/05/328/001/NO-002/NO | Cubicin | Norway | 16.2.2006 |
| EU/1/05/328/001-002 | Cubicin | Liechtenstein | 28.2.2006 |
| EU/1/05/328/001-002/IS | Cubicin | Iceland | 13.2.2006 |
| EU/1/05/329/001/NO-005/NO | Kiovig | Norway | 27.1.2006 |
| EU/1/05/329/001-005 | Kiovig | Liechtenstein | 31.1.2006 |
| EU/1/05/329/001-005/IS | Kiovig | Iceland | 10.2.2006 |
| EU/1/05/330/001/NO-004/NO | Rotarix | Norway | 8.3.2006 |
| EU/1/05/330/001-004 | Rotarix | Liechtenstein | 28.2.2006 |
| EU/1/05/330/001-004/IS | Rotarix | Iceland | 27.4.2006 |
| EU/1/05/331/001/NO-013/NO | Neupro | Norway | 17.3.2006 |
| EU/1/05/331/001-013 | Neupro | Liechtenstein | 28.2.2006 |
| EU/1/05/331/001-013/IS | Neupro | Iceland | 10.4.2006 |
| EU/1/06/332/001/NO-003/NO | Omnitrope | Norway | 5.5.2006 |
| EU/1/06/332/001-003 | Omnitrope | Liechtenstein | 30.4.2006 |
| EU/1/06/332/001-003/IS | Omnitrope | Iceland | 11.5.2006 |
| EU/1/06/333/001/NO-003/NO | Myozyme | Norway | 8.5.2006 |
| EU/1/06/333/001-003 | Myozyme | Liechtenstein | 30.4.2006 |
| EU/1/06/334/001/NO-004/NO | Evoltra | Norway | 27.6.2006 |
| EU/1/06/334/001-004/IS | Evoltra | Iceland | 26.6.2006 |
| EU/1/06/335/001 | Valtropin | Liechtenstein | 30.6.2006 |
| EU/1/06/335/001/IS | Valtropin | Iceland | 12.5.2006 |
| EU/1/06/335/001/NO | Valtropin | Norway | 24.5.2006 |
| EU/1/06/336/001 | Tygacil | Liechtenstein | 30.6.2006 |
| EU/1/06/336/001/IS | Tygacil | Iceland | 1.6.2006 |
| EU/1/06/336/001/NO | Tygacil | Norway | 24.5.2006 |
| EU/1/06/337/001/NO-013/NO | M-M-Rvaxpro | Norway | 19.5.2006 |
| EU/1/06/337/001-013 | M-M-Rvaxpro | Liechtenstein | 30.6.2006 |
| EU/1/06/337/001-013/IS | M-M-Rvaxpro | Iceland | 13.6.2006 |
| EU/1/06/338/001/NO-003/NO | DuoTrav | Norway | 10.5.2006 |
| EU/1/06/338/001-003 | DuoTrav | Liechtenstein | 30.6.2006 |
| EU/1/06/338/001-003/IS | DuoTrav | Iceland | 12.5.2006 |
| EU/1/06/339/001/NO-002/NO | Preotact | Norway | 19.5.2006 |
| EU/1/06/339/001-002 | Preotact | Liechtenstein | 30.6.2006 |
| EU/1/06/339/001-002/IS | Preotact | Iceland | 18.5.2006 |
| EU/1/06/340/001/NO-002/NO | Ganfort | Norway | 1.6.2006 |
| EU/1/06/340/001-002 | Ganfort | Liechtenstein | 30.6.2006 |
| EU/1/06/340/001-002/IS | Ganfort | Iceland | 15.6.2006 |
| EU/1/06/341/001/NO-013/NO | Zostavax | Norway | 6.6.2006 |
| EU/1/06/341/001-013 | Zostavax | Liechtenstein | 30.6.2006 |
| EU/1/06/341/001-013/IS | Zostavax | Iceland | 19.6.2006 |
| EU/1/06/344/001/NO-009/NO | Acomplia | Norway | 30.6.2006 |
| EU/1/06/344/001-009 | Acomplia | Liechtenstein | 30.6.2006 |
| EU/1/06/345/001/NO-009/NO | Zimulti | Norway | 30.6.2006 |
| EU/1/06/345/001-009 | Zimulti | Liechtenstein | 30.6.2006 |
| EU/1/96/022/019-022 | Zyprexa | Liechtenstein | 31.1.2006 |
| EU/1/97/043/003 | Revasc | Liechtenstein | 31.1.2006 |
| EU/1/97/044/007-008 | Tasmar | Liechtenstein | 28.2.2006 |
| EU/1/97/046/031-033 | Aprovel | Liechtenstein | 31.1.2006 |
| EU/1/97/049/031-033 | Karvea | Liechtenstein | 31.1.2006 |
| EU/1/97/055/003 | Viramune | Liechtenstein | 31.1.2006 |
| EU/1/98/063/007 | Rebif | Liechtenstein | 31.1.2006 |
| EU/2/00/025/001-004 | Advasure | Liechtenstein | 28.2.2006 |
| EU/2/03/037/005 | ProteqFlu | Liechtenstein | 28.2.2006 |
| EU/2/03/038/005 | ProteqFlu Te | Liechtenstein | 28.2.2006 |
| EU/2/04/043/001 | Equilis StrepE | Liechtenstein | 31.1.2006 |
| EU/2/04/044/001 | Aivlosin | Liechtenstein | 31.1.2006 |
| EU/2/04/044/002-005 | Aivlosin | Liechtenstein | 28.2.2006 |
| EU/2/06/058/001/NO-003/NO | Flexicam | Norway | 3.5.2006 |
| EU/2/06/058/001-003 | Flexicam | Liechtenstein | 30.4.2006 |
| EU/2/06/058/001-003/IS | Flexicam | Iceland | 22.4.2006 |
| EU/2/06/059/001 | Convenia | Liechtenstein | 30.6.2006 |
| EU/2/97/004/014-015 | Metacam | Liechtenstein | 28.2.2006 |

EU-Number

Product

Country

Date of authorisation

EU/1/01/183/020-029

HBVAXPRO

Liechtenstein

28.2.2006

EU/1/01/187/001

DepoCyte

Liechtenstein

31.1.2006

EU/1/03/258/015-022

Avandamet

Liechtenstein

28.2.2006

EU/1/03/262/001-006

Emend

Liechtenstein

31.1.2006

EU/1/03/265/003-004

Bonviva

Liechtenstein

31.1.2006

EU/1/03/266/001-002

Bondenza

Liechtenstein

28.2.2006

EU/1/04/307/005-010

Zonegran

Liechtenstein

31.1.2006

EU/1/05/322/001

Yttriga

Liechtenstein

31.1.2006

EU/1/05/322/001/IS

Yttriga

Iceland

17.2.2006

EU/1/05/322/001/NO

Yttriga

Norway

10.2.2006

EU/1/05/323/001/NO-011/NO

ProQuad

Norway

24.4.2006

EU/1/05/323/001-011

ProQuad

Liechtenstein

30.4.2006

EU/1/05/323/001-011/IS

ProQuad

Iceland

25.4.2006

EU/1/05/324/001

Naglazyme

Liechtenstein

31.1.2006

EU/1/05/324/001/IS

Naglazyme

Iceland

22.6.2006

EU/1/05/324/01/NO

Naglazyme

Norway

23.2.2006

EU/1/05/325/001

Macugen

Liechtenstein

28.2.2006

EU/1/05/325/001/IS

Macugen

Iceland

10.3.2006

EU/1/05/325/001/NO

Macugen

Norway

2.3.2006

EU/1/05/326/001

Ionsys

Liechtenstein

31.1.2006

EU/1/05/326/001/IS

Ionsys

Iceland

22.2.2006

EU/1/05/326/001/NO

Ionsys

Norway

16.2.2006

EU/1/05/327/001/NO-017/NO

Exubera

Norway

16.2.2006

EU/1/05/327/001-017

Exubera

Liechtenstein

31.1.2006

EU/1/05/327/001-017/IS

Exubera

Iceland

22.3.2006

EU/1/05/328/001/NO-002/NO

Cubicin

Norway

16.2.2006

EU/1/05/328/001-002

Cubicin

Liechtenstein

28.2.2006

EU/1/05/328/001-002/IS

Cubicin

Iceland

13.2.2006

EU/1/05/329/001/NO-005/NO

Kiovig

Norway

27.1.2006

EU/1/05/329/001-005

Kiovig

Liechtenstein

31.1.2006

EU/1/05/329/001-005/IS

Kiovig

Iceland

10.2.2006

EU/1/05/330/001/NO-004/NO

Rotarix

Norway

8.3.2006

EU/1/05/330/001-004

Rotarix

Liechtenstein

28.2.2006

EU/1/05/330/001-004/IS

Rotarix

Iceland

27.4.2006

EU/1/05/331/001/NO-013/NO

Neupro

Norway

17.3.2006

EU/1/05/331/001-013

Neupro

Liechtenstein

28.2.2006

EU/1/05/331/001-013/IS

Neupro

Iceland

10.4.2006

EU/1/06/332/001/NO-003/NO

Omnitrope

Norway

5.5.2006

EU/1/06/332/001-003

Omnitrope

Liechtenstein

30.4.2006

EU/1/06/332/001-003/IS

Omnitrope

Iceland

11.5.2006

EU/1/06/333/001/NO-003/NO

Myozyme

Norway

8.5.2006

EU/1/06/333/001-003

Myozyme

Liechtenstein

30.4.2006

EU/1/06/334/001/NO-004/NO

Evoltra

Norway

27.6.2006

EU/1/06/334/001-004/IS

Evoltra

Iceland

26.6.2006

EU/1/06/335/001

Valtropin

Liechtenstein

30.6.2006

EU/1/06/335/001/IS

Valtropin

Iceland

12.5.2006

EU/1/06/335/001/NO

Valtropin

Norway

24.5.2006

EU/1/06/336/001

Tygacil

Liechtenstein

30.6.2006

EU/1/06/336/001/IS

Tygacil

Iceland

1.6.2006

EU/1/06/336/001/NO

Tygacil

Norway

24.5.2006

EU/1/06/337/001/NO-013/NO

M-M-Rvaxpro

Norway

19.5.2006

EU/1/06/337/001-013

M-M-Rvaxpro

Liechtenstein

30.6.2006

EU/1/06/337/001-013/IS

M-M-Rvaxpro

Iceland

13.6.2006

EU/1/06/338/001/NO-003/NO

DuoTrav

Norway

10.5.2006

EU/1/06/338/001-003

DuoTrav

Liechtenstein

30.6.2006

EU/1/06/338/001-003/IS

DuoTrav

Iceland

12.5.2006

EU/1/06/339/001/NO-002/NO

Preotact

Norway

19.5.2006

EU/1/06/339/001-002

Preotact

Liechtenstein

30.6.2006

EU/1/06/339/001-002/IS

Preotact

Iceland

18.5.2006

EU/1/06/340/001/NO-002/NO

Ganfort

Norway

1.6.2006

EU/1/06/340/001-002

Ganfort

Liechtenstein

30.6.2006

EU/1/06/340/001-002/IS

Ganfort

Iceland

15.6.2006

EU/1/06/341/001/NO-013/NO

Zostavax

Norway

6.6.2006

EU/1/06/341/001-013

Zostavax

Liechtenstein

30.6.2006

EU/1/06/341/001-013/IS

Zostavax

Iceland

19.6.2006

EU/1/06/344/001/NO-009/NO

Acomplia

Norway

30.6.2006

EU/1/06/344/001-009

Acomplia

Liechtenstein

30.6.2006

EU/1/06/345/001/NO-009/NO

Zimulti

Norway

30.6.2006

EU/1/06/345/001-009

Zimulti

Liechtenstein

30.6.2006

EU/1/96/022/019-022

Zyprexa

Liechtenstein

31.1.2006

EU/1/97/043/003

Revasc

Liechtenstein

31.1.2006

EU/1/97/044/007-008

Tasmar

Liechtenstein

28.2.2006

EU/1/97/046/031-033

Aprovel

Liechtenstein

31.1.2006

EU/1/97/049/031-033

Karvea

Liechtenstein

31.1.2006

EU/1/97/055/003

Viramune

Liechtenstein

31.1.2006

EU/1/98/063/007

Rebif

Liechtenstein

31.1.2006

EU/2/00/025/001-004

Advasure

Liechtenstein

28.2.2006

EU/2/03/037/005

ProteqFlu

Liechtenstein

28.2.2006

EU/2/03/038/005

ProteqFlu Te

Liechtenstein

28.2.2006

EU/2/04/043/001

Equilis StrepE

Liechtenstein

31.1.2006

EU/2/04/044/001

Aivlosin

Liechtenstein

31.1.2006

EU/2/04/044/002-005

Aivlosin

Liechtenstein

28.2.2006

EU/2/06/058/001/NO-003/NO

Flexicam

Norway

3.5.2006

EU/2/06/058/001-003

Flexicam

Liechtenstein

30.4.2006

EU/2/06/058/001-003/IS

Flexicam

Iceland

22.4.2006

EU/2/06/059/001

Convenia

Liechtenstein

30.6.2006

EU/2/97/004/014-015

Metacam

Liechtenstein

28.2.2006

---

ANNEX II

List of renewed marketing authorisations

The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 January-30 June 2006:

| EU-Number | Product | Country | Date of renewal |
| --- | --- | --- | --- |
| EU/1/00/154/001/NO-002/NO | Neospect | Norway | 27.2.2006 |
| EU/1/00/154/001-002 | NeoSpect | Liechtenstein | 28.2.2006 |
| EU/1/00/154/001-002/IS | NeoSpect | Iceland | 22.2.2006 |
| EU/1/00/155/001/NO-006/NO | Luveris | Norway | 27.2.2006 |
| EU/1/00/155/001-006 | Luveris | Liechtenstein | 31.1.2006 |
| EU/1/00/155/001-006/IS | Luveris | Iceland | 25.4.2006 |
| EU/1/00/156/002/NO-003/NO | Trizivir | Norway | 27.4.2006 |
| EU/1/00/156/002-003 | Trizivir | Liechtenstein | 30.4.2006 |
| EU/1/00/157/001-034 | Azomyr | Liechtenstein | 28.2.2006 |
| EU/1/00/160/001-034 | Aerius | Liechtenstein | 28.2.2006 |
| EU/1/00/161/001-034 | Neoclarityn | Liechtenstein | 28.2.2006 |
| EU/1/00/163/001/NO | Xeloda | Norway | 3.3.2006 |
| EU/1/00/163/001-002 | Xeloda | Liechtenstein | 28.2.2006 |
| EU/1/00/163/001-002/IS | Xeloda | Iceland | 7.3.2006 |
| EU/1/00/163/002/NO | Xeloda | Norway | 3.3.2006 |
| EU/1/00/164/003/NO-006/NO | NutropinAq | Norway | 20.4.2006 |
| EU/1/00/164/003-005 | NutropinAq | Liechtenstein | 30.4.2006 |
| EU/1/00/164/003-005/IS | NutropinAq | Iceland | 18.5.2006 |
| EU/1/00/165/001/NO-007/NO | Ovitrelle | Norway | 2.3.2006 |
| EU/1/00/165/001-007 | Ovitrelle | Liechtenstein | 28.2.2006 |
| EU/1/00/165/007/IS | Ovitrelle | Iceland | 11.4.2006 |
| EU/1/00/166/001/NO-003/NO | NeuroBloc | Norway | 3.5.2006 |
| EU/1/00/166/001-003 | NeuroBloc | Liechtenstein | 30.4.2006 |
| EU/1/00/166/001-003/IS | NeuroBloc | Iceland | 9.6.2006 |
| EU/1/00/167/001/NO-007/NO | Prevenar | Norway | 3.5.2006 |
| EU/1/00/167/001-007 | Prevenar | Liechtenstein | 30.4.2006 |
| EU/1/00/167/001-007/IS | Prevenar | Iceland | 30.5.2006 |
| EU/1/00/169/002/NO-004/NO | Metalyse | Norway | 14.3.2006 |
| EU/1/00/169/004-006 | Metalyse | Liechtenstein | 30.4.2006 |
| EU/1/00/169/004-006/IS | Metalyse | Iceland | 11.4.2006 |
| EU/1/00/170/001/NO-002/NO | Fasturtec | Norway | 27.2.2006 |
| EU/1/00/170/001-002 | Fasturtec | Liechtenstein | 28.2.2006 |
| EU/1/00/170/001-002(IS | Fasturtec | Iceland | 7.3.2006 |
| EU/1/01/171/001,007-012/IS | Rapamune | Iceland | 8.6.2006 |
| EU/1/01/171/001/NO, 007/NO-012/NO | Rapamune | Norway | 5.5.2006 |
| EU/1/01/172/001/NO-003/NO | Kaletra | Norway | 26.4.2006 |
| EU/1/01/172/001-003 | Kaletra | Liechtenstein | 30.4.2006 |
| EU/1/01/172/001-003/IS | Kaletra | Iceland | 23.5.2006 |
| EU/1/01/173/001/NO-003/NO | Vaniqa | Norway | 9.5.2006 |
| EU/1/01/173/001-003 | Vaniqa | Liechtenstein | 30.4.2006 |
| EU/1/01/173/001-003/IS | Vaniqa | Iceland | 7.6.2006 |
| EU/1/01/174/001/NO-007/NO | Starlix | Norway | 23.5.2006 |
| EU/1/01/174/001-021 | Starlix | Liechtenstein | 30.6.2006 |
| EU/1/01/174/001-021/IS | Starlix | Iceland | 7.6.2006 |
| EU/1/01/175/001, 004-007, 008, 011-014, 015, 018-021/IS | Trazec | Iceland | 7.6.2006 |
| EU/1/01/175/001, 004-008, 011-015, 018-021 | Trazec | Liechtenstein | 30.6.2006 |
| EU/1/01/175/001/NO, 004/NO-007/NO, 008/NO, 011/NO-014/NO, 015/NO, 018/NO-021/NO | Trazec | Norway | 23.5.2006 |
| EU/1/01/176/001/NO-003/NO | Zometa | Norway | 2.5.2006 |
| EU/1/01/176/001-006 | Zometa | Liechtenstein | 30.6.2006 |
| EU/1/01/176/001-006/IS | Zometa | Iceland | 22.5.2006 |
| EU/1/01/177/001/NO-002/NO | SonoVue | Norway | 4.5.2006 |
| EU/1/01/177/001-002 | SonoVue | Liechtenstein | 30.4.2006 |
| EU/1/01/177/002/IS | SonoVue | Iceland | 8.6.2006 |
| EU/1/01/178/001/IS | Targretin | Iceland | 9.6.2006 |
| EU/1/01/178/001/NO | Targretin | Norway | 16.5.2006 |
| EU/1/01/179/001 | Osigraft | Liechtenstein | 30.6.2006 |
| EU/1/01/179/001/NO | Osigraft | Norway | 30.5.2006 |
| EU/1/01/184/001/NO-056/NO | Nespo | Norway | 26.6.2006 |
| EU/1/01/184/001-056 | Nespo | Liechtenstein | 30.6.2006 |
| EU/1/01/185/001/NO-056/NO | Aranesp | Norway | 26.6.2006 |
| EU/1/01/185/001-056 | Aranesp | Liechtenstein | 30.6.2006 |
| EU/1/01/187/001 | DepoCyte | Liechtenstein | 30.6.2006 |
| EU/1/01/195/001/NO-015 /NO | Liprolog | Norway | 14.3.2006 |
| EU/1/01/195/001-015 | Liprolog | Liechtenstein | 28.2.2006 |
| EU/1/01/195/001-015/IS | Liprolog | Iceland | 13.3.2006 |
| EU/1/03/262/007-008/IS | Emend | Iceland | 19.6.2006 |
| EU/1/95/001/001, 003-005, 009, 012, 021-022, 025-028, 031-035 | Gonal-f | Liechtenstein | 31.1.2006 |
| EU/1/95/002/001/NO-002/NO | Taxotere | Norway | 23.2.2006 |
| EU/1/95/002/001-002 | Taxotere | Liechtenstein | 31.1.2006 |
| EU/1/95/002/001-002/IS | Taxotere | Iceland | 23.2.2006 |
| EU/1/95/003/003/NO-004/NO | Betaferon | Norway | 2.3.2006 |
| EU/1/95/003/003-004 | Betaferon | Liechtenstein | 28.2.2006 |
| EU/1/95/003/003-004/IS | Betaferon | Iceland | 10.4.2006 |
| EU/1/96/004/001/NO-002/NO | Fareston | Norway | 1.3.2006 |
| EU/1/96/004/001-002 | Fareston | Liechtenstein | 28.2.2006 |
| EU/1/96/005/001/NO-006/NO | CellCept | Norway | 6.4.2006 |
| EU/1/96/005/001-006 | CellCept | Liechtenstein | 30.4.2006 |
| EU/1/96/005/001-006/IS | CellCept | Iceland | 5.5.2006 |
| EU/1/96/006/001/NO-003/NO | Novoseven | Norway | 3.3.2006 |
| EU/1/96/006/001-003 | NovoSeven | Liechtenstein | 28.2.2006 |
| EU/1/96/006/001-003/IS | NovoSeven | Iceland | 10.4.2006 |
| EU/1/96/007/002, 004-006, 008, 010-011, 015-021, 023-030 | Humalog | Liechtenstein | 30.4.2006 |
| EU/1/96/007/002, 004-006, 008, 010-011, 015-021, 023-030/IS | Humalog | Iceland | 13.3.2006 |
| EU/1/96/007/002/NO, 004/NO-006/NO, 008/NO, 010/NO-011/NO, 015/NO-021/NO, 023/NO-030/NO | Humalog | Norway | 3.3.2006 |
| EU/1/96/008/001/NO-040/NO | Puregon | Norway | 26.6.2006 |
| EU/1/96/008/001-041 | Puregon | Liechtenstein | 30.6.2006 |
| EU/1/96/009/001/NO-002/NO | Zerit | Norway | 2.5.2006 |
| EU/1/96/009/001-009 | Zerit | Liechtenstein | 30.4.2006 |
| EU/1/96/009/001-009/IS | Zerit | Iceland | 24.5.2006 |
| EU/1/96/011/001/NO-004/NO | Caelyx | Norway | 26.5.2006 |
| EU/1/96/011/001-004 | Caelyx | Liechtenstein | 30.6.2006 |
| EU/1/96/011/001-004/IS | Caelyx | Iceland | 16.6.2006 |
| EU/1/98/093/002/IS | Forcaltonin | Iceland | 31.5.2006 |
| EU/1/98/093/002/NO | Forcaltonin | Norway | 21.6.2006 |
| EU/2/00/019/001-003/IS | Purevax FeLV | Iceland | 9.3.2006 |
| EU/2/00/025/001/NO-004/NO | Advasure | Norway | 15.3.2006 |
| EU/2/00/026/001/NO-004/NO | Porcilis AR-T DF | Norway | 10.3.2006 |
| EU/2/00/026/001-004 | Porcilis AR-T DF | Liechtenstein | 28.2.2006 |
| EU/2/00/026/001-004/IS | Porcilis AR-T DF | Iceland | 8.3.2006 |
| EU/2/00/027/001/NO-003/NO | Pirsue | Norway | 10.3.2006 |
| EU/2/00/027/001-003 | Pirsue | Liechtenstein | 28.2.2006 |
| EU/2/00/028/002/NO-008 /NO | Zubrin | Norway | 7.4.2006 |
| EU/2/00/028/002-008 | Zubrin | Liechtenstein | 30.4.2006 |
| EU/2/00/028/002-008/IS | Zubrin | Iceland | 11.4.2006 |
| EU/2/01/029/001/NO-003/NO | Eurican Herpes | Norway | 18.5.2006 |
| EU/2/01/029/001-003 | Eurican Herpes | Liechtenstein | 30.4.2006 |
| EU/2/01/029/001-003/IS | Eurican Herpes | Iceland | 8.6.2006 |
| EU/2/96/001/001-010 | Porcilis Porcoli | Liechtenstein | 30.4.2006 |
| EU/2/96/001/NO-010/NO | Porcilis Porcoli | Norway | 5.5.2006 |

EU-Number

Product

Country

Date of renewal

EU/1/00/154/001/NO-002/NO

Neospect

Norway

27.2.2006

EU/1/00/154/001-002

NeoSpect

Liechtenstein

28.2.2006

EU/1/00/154/001-002/IS

NeoSpect

Iceland

22.2.2006

EU/1/00/155/001/NO-006/NO

Luveris

Norway

27.2.2006

EU/1/00/155/001-006

Luveris

Liechtenstein

31.1.2006

EU/1/00/155/001-006/IS

Luveris

Iceland

25.4.2006

EU/1/00/156/002/NO-003/NO

Trizivir

Norway

27.4.2006

EU/1/00/156/002-003

Trizivir

Liechtenstein

30.4.2006

EU/1/00/157/001-034

Azomyr

Liechtenstein

28.2.2006

EU/1/00/160/001-034

Aerius

Liechtenstein

28.2.2006

EU/1/00/161/001-034

Neoclarityn

Liechtenstein

28.2.2006

EU/1/00/163/001/NO

Xeloda

Norway

3.3.2006

EU/1/00/163/001-002

Xeloda

Liechtenstein

28.2.2006

EU/1/00/163/001-002/IS

Xeloda

Iceland

7.3.2006

EU/1/00/163/002/NO

Xeloda

Norway

3.3.2006

EU/1/00/164/003/NO-006/NO

NutropinAq

Norway

20.4.2006

EU/1/00/164/003-005

NutropinAq

Liechtenstein

30.4.2006

EU/1/00/164/003-005/IS

NutropinAq

Iceland

18.5.2006

EU/1/00/165/001/NO-007/NO

Ovitrelle

Norway

2.3.2006

EU/1/00/165/001-007

Ovitrelle

Liechtenstein

28.2.2006

EU/1/00/165/007/IS

Ovitrelle

Iceland

11.4.2006

EU/1/00/166/001/NO-003/NO

NeuroBloc

Norway

3.5.2006

EU/1/00/166/001-003

NeuroBloc

Liechtenstein

30.4.2006

EU/1/00/166/001-003/IS

NeuroBloc

Iceland

9.6.2006

EU/1/00/167/001/NO-007/NO

Prevenar

Norway

3.5.2006

EU/1/00/167/001-007

Prevenar

Liechtenstein

30.4.2006

EU/1/00/167/001-007/IS

Prevenar

Iceland

30.5.2006

EU/1/00/169/002/NO-004/NO

Metalyse

Norway

14.3.2006

EU/1/00/169/004-006

Metalyse

Liechtenstein

30.4.2006

EU/1/00/169/004-006/IS

Metalyse

Iceland

11.4.2006

EU/1/00/170/001/NO-002/NO

Fasturtec

Norway

27.2.2006

EU/1/00/170/001-002

Fasturtec

Liechtenstein

28.2.2006

EU/1/00/170/001-002(IS

Fasturtec

Iceland

7.3.2006

EU/1/01/171/001,007-012/IS

Rapamune

Iceland

8.6.2006

EU/1/01/171/001/NO, 007/NO-012/NO

Rapamune

Norway

5.5.2006

EU/1/01/172/001/NO-003/NO

Kaletra

Norway

26.4.2006

EU/1/01/172/001-003

Kaletra

Liechtenstein

30.4.2006

EU/1/01/172/001-003/IS

Kaletra

Iceland

23.5.2006

EU/1/01/173/001/NO-003/NO

Vaniqa

Norway

9.5.2006

EU/1/01/173/001-003

Vaniqa

Liechtenstein

30.4.2006

EU/1/01/173/001-003/IS

Vaniqa

Iceland

7.6.2006

EU/1/01/174/001/NO-007/NO

Starlix

Norway

23.5.2006

EU/1/01/174/001-021

Starlix

Liechtenstein

30.6.2006

EU/1/01/174/001-021/IS

Starlix

Iceland

7.6.2006

EU/1/01/175/001, 004-007, 008, 011-014, 015, 018-021/IS

Trazec

Iceland

7.6.2006

EU/1/01/175/001, 004-008, 011-015, 018-021

Trazec

Liechtenstein

30.6.2006

EU/1/01/175/001/NO, 004/NO-007/NO, 008/NO, 011/NO-014/NO, 015/NO, 018/NO-021/NO

Trazec

Norway

23.5.2006

EU/1/01/176/001/NO-003/NO

Zometa

Norway

2.5.2006

EU/1/01/176/001-006

Zometa

Liechtenstein

30.6.2006

EU/1/01/176/001-006/IS

Zometa

Iceland

22.5.2006

EU/1/01/177/001/NO-002/NO

SonoVue

Norway

4.5.2006

EU/1/01/177/001-002

SonoVue

Liechtenstein

30.4.2006

EU/1/01/177/002/IS

SonoVue

Iceland

8.6.2006

EU/1/01/178/001/IS

Targretin

Iceland

9.6.2006

EU/1/01/178/001/NO

Targretin

Norway

16.5.2006

EU/1/01/179/001

Osigraft

Liechtenstein

30.6.2006

EU/1/01/179/001/NO

Osigraft

Norway

30.5.2006

EU/1/01/184/001/NO-056/NO

Nespo

Norway

26.6.2006

EU/1/01/184/001-056

Nespo

Liechtenstein

30.6.2006

EU/1/01/185/001/NO-056/NO

Aranesp

Norway

26.6.2006

EU/1/01/185/001-056

Aranesp

Liechtenstein

30.6.2006

EU/1/01/187/001

DepoCyte

Liechtenstein

30.6.2006

EU/1/01/195/001/NO-015 /NO

Liprolog

Norway

14.3.2006

EU/1/01/195/001-015

Liprolog

Liechtenstein

28.2.2006

EU/1/01/195/001-015/IS

Liprolog

Iceland

13.3.2006

EU/1/03/262/007-008/IS

Emend

Iceland

19.6.2006

EU/1/95/001/001, 003-005, 009, 012, 021-022, 025-028, 031-035

Gonal-f

Liechtenstein

31.1.2006

EU/1/95/002/001/NO-002/NO

Taxotere

Norway

23.2.2006

EU/1/95/002/001-002

Taxotere

Liechtenstein

31.1.2006

EU/1/95/002/001-002/IS

Taxotere

Iceland

23.2.2006

EU/1/95/003/003/NO-004/NO

Betaferon

Norway

2.3.2006

EU/1/95/003/003-004

Betaferon

Liechtenstein

28.2.2006

EU/1/95/003/003-004/IS

Betaferon

Iceland

10.4.2006

EU/1/96/004/001/NO-002/NO

Fareston

Norway

1.3.2006

EU/1/96/004/001-002

Fareston

Liechtenstein

28.2.2006

EU/1/96/005/001/NO-006/NO

CellCept

Norway

6.4.2006

EU/1/96/005/001-006

CellCept

Liechtenstein

30.4.2006

EU/1/96/005/001-006/IS

CellCept

Iceland

5.5.2006

EU/1/96/006/001/NO-003/NO

Novoseven

Norway

3.3.2006

EU/1/96/006/001-003

NovoSeven

Liechtenstein

28.2.2006

EU/1/96/006/001-003/IS

NovoSeven

Iceland

10.4.2006

EU/1/96/007/002, 004-006, 008, 010-011, 015-021, 023-030

Humalog

Liechtenstein

30.4.2006

EU/1/96/007/002, 004-006, 008, 010-011, 015-021, 023-030/IS

Humalog

Iceland

13.3.2006

EU/1/96/007/002/NO, 004/NO-006/NO, 008/NO, 010/NO-011/NO, 015/NO-021/NO, 023/NO-030/NO

Humalog

Norway

3.3.2006

EU/1/96/008/001/NO-040/NO

Puregon

Norway

26.6.2006

EU/1/96/008/001-041

Puregon

Liechtenstein

30.6.2006

EU/1/96/009/001/NO-002/NO

Zerit

Norway

2.5.2006

EU/1/96/009/001-009

Zerit

Liechtenstein

30.4.2006

EU/1/96/009/001-009/IS

Zerit

Iceland

24.5.2006

EU/1/96/011/001/NO-004/NO

Caelyx

Norway

26.5.2006

EU/1/96/011/001-004

Caelyx

Liechtenstein

30.6.2006

EU/1/96/011/001-004/IS

Caelyx

Iceland

16.6.2006

EU/1/98/093/002/IS

Forcaltonin

Iceland

31.5.2006

EU/1/98/093/002/NO

Forcaltonin

Norway

21.6.2006

EU/2/00/019/001-003/IS

Purevax FeLV

Iceland

9.3.2006

EU/2/00/025/001/NO-004/NO

Advasure

Norway

15.3.2006

EU/2/00/026/001/NO-004/NO

Porcilis AR-T DF

Norway

10.3.2006

EU/2/00/026/001-004

Porcilis AR-T DF

Liechtenstein

28.2.2006

EU/2/00/026/001-004/IS

Porcilis AR-T DF

Iceland

8.3.2006

EU/2/00/027/001/NO-003/NO

Pirsue

Norway

10.3.2006

EU/2/00/027/001-003

Pirsue

Liechtenstein

28.2.2006

EU/2/00/028/002/NO-008 /NO

Zubrin

Norway

7.4.2006

EU/2/00/028/002-008

Zubrin

Liechtenstein

30.4.2006

EU/2/00/028/002-008/IS

Zubrin

Iceland

11.4.2006

EU/2/01/029/001/NO-003/NO

Eurican Herpes

Norway

18.5.2006

EU/2/01/029/001-003

Eurican Herpes

Liechtenstein

30.4.2006

EU/2/01/029/001-003/IS

Eurican Herpes

Iceland

8.6.2006

EU/2/96/001/001-010

Porcilis Porcoli

Liechtenstein

30.4.2006

EU/2/96/001/NO-010/NO

Porcilis Porcoli

Norway

5.5.2006

---

ANNEX III

List of extended marketing authorisations

The following marketing authorisations have been extended in the EEA EFTA States during the period 1 January-30 June 2006:

| EU-Number | Product | Country | Date of extention |
| --- | --- | --- | --- |
| EU/1/00/137/013-018 | Avandia | Liechtenstein | 30.6.2006 |
| EU/1/00/146/030 | Keppra | Liechtenstein | 30.4.2006 |
| EU/1/00/146/030/IS | Keppra | Iceland | 7.4.2006 |
| EU/1/00/146/030/NO | Keppra | Norway | 28.4.2006 |
| EU/1/00/150/016-024 | Actos | Liechtenstein | 30.4.2006 |
| EU/1/00/151/014-022 | Glustin | Liechtenstein | 30.4.2006 |
| EU/1/00/162/019-021 | Prandin | Liechtenstein | 30.6.2006 |
| EU/1/03/255/004-005 | Ventavis | Liechtenstein | 30.6.2006 |
| EU/1/03/262/007/NO-008/NO | Emend | Norway | 28.6.2006 |
| EU/1/03/262/007-008 | Emend | Liechtenstein | 30.6.2006 |
| EU/1/03/262/007-008/IS | Emend | Iceland | 19.6.2006 |
| EU/1/03/265/005/NO-006/NO | Bonviva | Norway | 2.5.2006 |
| EU/1/03/265/005-006/IS | Bonviva | Iceland | 12.6.2006 |
| EU/1/03/266/005/NO-006/NO | Bondenza | Norway | 8.5.2006 |
| EU/1/04/279/033/NO-035/NO | Lyrica | Norway | 19.6.2006 |
| EU/1/04/279/033-035 | Lyrica | Liechtenstein | 30.6.2006 |
| EU/1/04/296/007 | Cymbalta | Liechtenstein | 30.4.2006 |
| EU/1/04/296/008 | Cymbalta | Liechtenstein | 30.6.2006 |
| EU/1/04/297/007 | Xeristar | Liechtenstein | 30.4.2006 |
| EU/1/04/297/008 | Xeristar | Liechtenstein | 30.6.2006 |
| EU/1/04/302/004 | Prialt | Liechtenstein | 30.4.2006 |
| EU/1/04/302/004/IS | Prialt | Iceland | 22.4.2006 |
| EU/1/04/302/004/NO | Prialt | Norway | 29.3.2006 |
| EU/1/05/319/003-004 | Xolair | Liechtenstein | 30.6.2006 |
| EU/1/96/007/029-030 | Humalog | Liechtenstein | 30.4.2006 |
| EU/1/98/063/007/IS | Rebif | Iceland | 30.5.2006 |
| EU/1/98/063/007/NO | Rebif | Norway | 16.2.2006 |
| EU/1/98/076/022-024 | NovoNorm | Liechtenstein | 30.6.2006 |
| EU/1/98/089/017-019 | Pritor | Liechtenstein | 30.4.2006 |
| EU/1/99/107/005 | Rebetol | Liechtenstein | 30.4.2006 |
| EU/2/00/019/005-007/IS | Purevax FeL V | Iceland | 9.3.2006 |
| EU/2/02/035/007 | SevoFlo | Liechtenstein | 30.4.2006 |
| EU/2/03/037/005/NO | Proteqflu | Norway | 15.3.2006 |
| EU/2/03/038/005/NO | Proteqflu-Te | Norway | 15.3.2006 |
| EU/2/04/044/002/NO | Aivlosin | Norway | 4.3.2006 |
| EU/2/04/044/003-005/IS | Aivlosin | Iceland | 22.3.2006 |
| EU/2/97/004/016/NO-023/NO | Metacam | Norway | 22.4.2006 |
| EU/2/97/004/016-023 | Metacam | Liechtenstein | 30.4.2006 |
| EU/2/97/004/016-023/IS | Metacam | Iceland | 7.4.2006 |

EU-Number

Product

Country

Date of extention

EU/1/00/137/013-018

Avandia

Liechtenstein

30.6.2006

EU/1/00/146/030

Keppra

Liechtenstein

30.4.2006

EU/1/00/146/030/IS

Keppra

Iceland

7.4.2006

EU/1/00/146/030/NO

Keppra

Norway

28.4.2006

EU/1/00/150/016-024

Actos

Liechtenstein

30.4.2006

EU/1/00/151/014-022

Glustin

Liechtenstein

30.4.2006

EU/1/00/162/019-021

Prandin

Liechtenstein

30.6.2006

EU/1/03/255/004-005

Ventavis

Liechtenstein

30.6.2006

EU/1/03/262/007/NO-008/NO

Emend

Norway

28.6.2006

EU/1/03/262/007-008

Emend

Liechtenstein

30.6.2006

EU/1/03/262/007-008/IS

Emend

Iceland

19.6.2006

EU/1/03/265/005/NO-006/NO

Bonviva

Norway

2.5.2006

EU/1/03/265/005-006/IS

Bonviva

Iceland

12.6.2006

EU/1/03/266/005/NO-006/NO

Bondenza

Norway

8.5.2006

EU/1/04/279/033/NO-035/NO

Lyrica

Norway

19.6.2006

EU/1/04/279/033-035

Lyrica

Liechtenstein

30.6.2006

EU/1/04/296/007

Cymbalta

Liechtenstein

30.4.2006

EU/1/04/296/008

Cymbalta

Liechtenstein

30.6.2006

EU/1/04/297/007

Xeristar

Liechtenstein

30.4.2006

EU/1/04/297/008

Xeristar

Liechtenstein

30.6.2006

EU/1/04/302/004

Prialt

Liechtenstein

30.4.2006

EU/1/04/302/004/IS

Prialt

Iceland

22.4.2006

EU/1/04/302/004/NO

Prialt

Norway

29.3.2006

EU/1/05/319/003-004

Xolair

Liechtenstein

30.6.2006

EU/1/96/007/029-030

Humalog

Liechtenstein

30.4.2006

EU/1/98/063/007/IS

Rebif

Iceland

30.5.2006

EU/1/98/063/007/NO

Rebif

Norway

16.2.2006

EU/1/98/076/022-024

NovoNorm

Liechtenstein

30.6.2006

EU/1/98/089/017-019

Pritor

Liechtenstein

30.4.2006

EU/1/99/107/005

Rebetol

Liechtenstein

30.4.2006

EU/2/00/019/005-007/IS

Purevax FeL V

Iceland

9.3.2006

EU/2/02/035/007

SevoFlo

Liechtenstein

30.4.2006

EU/2/03/037/005/NO

Proteqflu

Norway

15.3.2006

EU/2/03/038/005/NO

Proteqflu-Te

Norway

15.3.2006

EU/2/04/044/002/NO

Aivlosin

Norway

4.3.2006

EU/2/04/044/003-005/IS

Aivlosin

Iceland

22.3.2006

EU/2/97/004/016/NO-023/NO

Metacam

Norway

22.4.2006

EU/2/97/004/016-023

Metacam

Liechtenstein

30.4.2006

EU/2/97/004/016-023/IS

Metacam

Iceland

7.4.2006

---

ANNEX IV

List of withdrawn marketing authorisations

The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 January-30 June 2006:

| EU-Number | Product | Country | Date of withdrawal |
| --- | --- | --- | --- |
| EU/1/00/137/001 | Avandia | Liechtenstein | 30.6.2006 |
| EU/1/01/183/002-003, 006, 009-010, 012, 014, 016-17 | HBVAXPRO | Liechtenstein | 28.2.2006 |
| EU/1/02/245/001 | Theryttrex | Liechtenstein | 28.2.2006 |
| EU/1/02/245/001/IS | Theryttrex | Iceland | 10.2.2006 |
| EU/1/06/024/006, 009 | Crixivan | Liechstenstein | 31.1.2006 |
| EU/1/96/022/001, 003, 005, 007, 013, 015 | Zyprexa | Liechstenstein | 31.1.2006 |
| EU/1/97/052/001/NO-006/NO, 009/NO-010/NO | Daquiran | Norway | 22.2.2006 |
| EU/1/97/052/001-006, 009-010 | Daquiran | Liechtenstein | 28.2.2006 |
| EU/1/97/052/001-010/IS | Daquiran | Iceland | 10.2.2006 |
| EU/1/98/075/001-002 | Fortovase | Liechtenstein | 30.6.2006 |
| EU/1/98/075/001-002/IS | Fortovase- Saquinavir | Iceland | 26.6.2006 |
| EU/1/98/087/001/NO-003/NO | Infergen | Norway | 30.5.2006 |
| EU/1/98/087/001-003 | Infergen | Liechtenstein | 30.6.2006 |
| EU/1/98/087/001-003/IS | Infergen | Iceland | 16.6.2006 |
| EU/2/00/028/001 | Zubrin | Liechtenstein | 28.2.2006 |
| EU/2/98/010/001-003, 015-016, 019-020 | Econor | Liechtenstein | 31.1.2006 |

EU-Number

Product

Country

Date of withdrawal

EU/1/00/137/001

Avandia

Liechtenstein

30.6.2006

EU/1/01/183/002-003, 006, 009-010, 012, 014, 016-17

HBVAXPRO

Liechtenstein

28.2.2006

EU/1/02/245/001

Theryttrex

Liechtenstein

28.2.2006

EU/1/02/245/001/IS

Theryttrex

Iceland

10.2.2006

EU/1/06/024/006, 009

Crixivan

Liechstenstein

31.1.2006

EU/1/96/022/001, 003, 005, 007, 013, 015

Zyprexa

Liechstenstein

31.1.2006

EU/1/97/052/001/NO-006/NO, 009/NO-010/NO

Daquiran

Norway

22.2.2006

EU/1/97/052/001-006, 009-010

Daquiran

Liechtenstein

28.2.2006

EU/1/97/052/001-010/IS

Daquiran

Iceland

10.2.2006

EU/1/98/075/001-002

Fortovase

Liechtenstein

30.6.2006

EU/1/98/075/001-002/IS

Fortovase- Saquinavir

Iceland

26.6.2006

EU/1/98/087/001/NO-003/NO

Infergen

Norway

30.5.2006

EU/1/98/087/001-003

Infergen

Liechtenstein

30.6.2006

EU/1/98/087/001-003/IS

Infergen

Iceland

16.6.2006

EU/2/00/028/001

Zubrin

Liechtenstein

28.2.2006

EU/2/98/010/001-003, 015-016, 019-020

Econor

Liechtenstein

31.1.2006

---

ANNEX V

List of suspended marketing authorisations

The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 January-30 June 2006:

| EU-Number | Product | Country | Date of suspention |
| --- | --- | --- | --- |
| EU/1/02/239/001-030 | Bextra | Liechtenstein | 31.1.2006 |

EU-Number

Product

Country

Date of suspention

EU/1/02/239/001-030

Bextra

Liechtenstein

31.1.2006

---